Specific Biologics Announces Additional Investment And Appointment Of Experienced Biotechnology Leader Steven Kanner, Phd, To The Board Of Directors
Round Type
Venture
TorontoInformation TechnologyBiotechnologyHealth CareScience And EngineeringLending And InvestmentsInvestors
Description
Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Steven Kanner, PhD, as an Independent Director. Dr. Kanner joins Brent Stead, PhD, MBA, as well as seasoned company builders Daniel Hétu, MD, MBA of Lumira Ventures, Nikhil Thatte, B.Eng of Lumira Ventures and Frédéric Lemaître Auger, MSc, PhD, MBA of adMare BioInnovations
Quick answer
Specific Biologics raised an undisclosed amount in a funding round, dated October 10, 2023. Investors: Ad Mare Bio Innovations, Lumira Ventures, Frédéric Lemaître Auger, M Sc, Ph D, Mba Of Ad Mare Bio Innovations, Nikhil Thatte, B.Eng Of Lumira Ventures, Daniel Hétu, Md, Mba Of Lumira Ventures, Brent Stead, Ph D, Mba and Dr. Kanner. Specific Biologics is based in Toronto, Ontario, Canada.
- How much did Specific Biologics raise?
- Specific Biologics raised an undisclosed amount in a funding round on October 10, 2023.
- Who invested in Specific Biologics?
- Ad Mare Bio Innovations, Lumira Ventures, Frédéric Lemaître Auger, M Sc, Ph D, Mba Of Ad Mare Bio Innovations, Nikhil Thatte, B.Eng Of Lumira Ventures, Daniel Hétu, Md, Mba Of Lumira Ventures, Brent Stead, Ph D, Mba and Dr. Kanner are named as investors in this round.
- What does Specific Biologics do?
- Specific Biologics Inc. ("Specific") is a venture-backed early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through efficient and precise gene editing.
- Where is Specific Biologics based and how big is it?
- Specific Biologics is based in Toronto, Ontario, Canada. Fundz records about 2 employees.
- Who are the decision-makers at Specific Biologics?
- Fundz holds 4 contacts at Specific Biologics, including the Associate Director - Pipeline Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Lending And Investments around the same time
Companies in the same sectors as Specific Biologics that raised within 45 days of this round, from Fundz verified event records.
- MAIA Biotechnology raised $4.9M (Seed) on November 15, 2023.
- Zephyr AI, Inc. raised $111M on October 27, 2023.
- Trait Biosciences Inc. raised an undisclosed amount (Funding Round) on October 11, 2023.
- Deka Biosciences, Inc. raised $20M (Series B) on September 28, 2023.
- RedHill Biopharma Ltd raised $4M (Seed) on September 28, 2023.
- Geneos Therapeutics raised an undisclosed amount (Series A) on September 27, 2023.
Who to call at Specific Biologics, and when
A new round usually means Specific Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Specific Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Specific Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Specific Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Specific Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Specific Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.